Avinger: Surges on full commercial launch of Tigereye device

Avinger

15/01/2021 16:01

** Medical device maker's shares  AVGR.O  up 31.5% at $1.46
    ** Stock among top pct gainers on Nasdaq
    ** Co announces full commercial launch of its medical
device, Tigereye  urn:newsml:reuters.com:*:nACS9xYZwa
    ** With the launch, current and prospective accounts
throughout the United States and Germany are now able to order
the Tigereye device - co
    ** TigerEye, used for patients with peripheral artery
disease, provides imaging from inside vessels during a surgical
procedure known as chronic total occlusion (CTO) crossing
    ** During Q4 2020, co conducted a limited launch at 12
clinical centers in the United States and Germany, in which
about 50 CTO cases were successfully performed
    

 (Reporting by Rithika Krishna)
 ((Rithika.Krishna@thomsonreuters.com;))